Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Current Assets: 2020-2024

Historic Current Assets for Molecular Partners Ag (MOLN) over the last 5 years, with Dec 2024 value amounting to $175.4 million.

  • Molecular Partners Ag's Current Assets fell 21.08% to $136,208 in Q3 2025 from the same period last year, while for Sep 2025 it was $136,208, marking a year-over-year decrease of 21.08%. This contributed to the annual value of $175.4 million for FY2024, which is 81737.55% up from last year.
  • Molecular Partners Ag's Current Assets amounted to $175.4 million in FY2024, which was up 81,737.55% from $214,292 recorded in FY2023.
  • In the past 5 years, Molecular Partners Ag's Current Assets registered a high of $196.7 million during FY2020, and its lowest value of $178,065 during FY2021.
  • Over the past 3 years, Molecular Partners Ag's median Current Assets value was $264,438 (recorded in 2022), while the average stood at $58.6 million.
  • Its Current Assets has fluctuated over the past 5 years, first slumped by 99.91% in 2021, then soared by 81,737.55% in 2024.
  • Yearly analysis of 5 years shows Molecular Partners Ag's Current Assets stood at $196.7 million in 2020, then plummeted by 99.91% to $178,065 in 2021, then spiked by 48.51% to $264,438 in 2022, then decreased by 18.96% to $214,292 in 2023, then spiked by 81,737.55% to $175.4 million in 2024.